We chose the AAFP of two good-risk AMLs — the t(8;21)-related RUNX1/RUNX1T1 and the t(15;17)-related PML/RARα — and of one poor risk AML — the t(6;9)-related DEK/NUP214 (Figure 1A). Here, PML is linked to acute myeloid leukemia.